The Sequential One-Pot Reaction of Isatylidene Malononitriles and 4-Hydrazinocoumarin: Metal Catalyst-Free and Efficient Access to Coumarin-Fused Spiro[diazepin-5,3′-oxindole]

Abdolali Alizadeh; Hamidreza Hasanpour

doi:10.1055/a-2738-8145

Synthesis, Table of Contents

Synthesis
DOI: 10.1055/a-2738-8145

Paper

The Sequential One-Pot Reaction of Isatylidene Malononitriles and 4-Hydrazinocoumarin: Metal Catalyst-Free and Efficient Access to Coumarin-Fused Spiro[diazepin-5,3′-oxindole]

Authors

Abdolali Alizadeh

¹Faculty of Basic Sciences, Department of Chemistry, Tarbiat Modares University, Tehran, Iran (the Islamic Republic of) (Ringgold ID: RIN98777)
Hamidreza Hasanpour

¹Faculty of Basic Sciences, Department of Chemistry, Tarbiat Modares University, Tehran, Iran (the Islamic Republic of) (Ringgold ID: RIN98777)

Abstract

All articles of this category

Abstract

The synthesis of hybrid heterocycles (spiro and fused heterocycles) is a golden opportunity to access novel compounds with unique photophysical and pharmaceutical properties. Therefore, an efficient and metal catalyst-free procedure was designed to prepare novel coumarin-fused spiro[diazepin-5,3′-oxindole] derivatives through a three-component, sequential, one-pot reaction. This method involves the use of various isatin derivatives, malononitrile, and 4-hydrazinocoumarin. The significance of this method lies in the accessibility of the mentioned raw materials and easy purification of the products by filtering and washing with a solvent.

Keywords

Isatin - Malononitrile - 4-Hydrazinocoumarin - Isatylidene Malononitrile - Coumarin-fused Spiro[diazepin-5,3′-oxindole] - Spiro-oxindoles - [1,2]-Diazepines - Spiro[diazepin-5,3′-oxindole]

Full Text

References

References
1 Liu W, Khedkar V, Baskar B, Schürmann M, Kumar K. Angew Chem Int Ed 2011; 50: 6900
2 Takikawa H, Nishii A, Sakai T, Suzuki K. Chem Soc Rev 2018; 47: 8030
3 Xia M, Ma R-Z. J Heterocycl Chem 2014; 51: 539
4 Saraswat P, Jeyabalan G, Hassan MZ, Rahman MU, Nyola NK. Synth Commun 2016; 46: 1643
5 Muylaert K, Jatczak M, Mangelinckx S, Stevens V, Curr C. Med Chem 2016; 23: 4784
6 Küpeli Akkol E, Genç Y, Karpuz B, Sobarzo-Sánchez E, Capasso R. Cancers 2020; 12: 1959
7 Zhou L-M, Qu R-Y, Yang G-F. Expert Opin Drug Discov 2020; 15: 603
8 Nasri S, Bayat M, Mirzaei F. Top Curr Chem 2021; 379: 25
9 Salehian F, Nadri H, Jalili-Baleh L. et al. Eur J Med Chem 2021; 212: 113034
10 Pasricha S, Mittal K, Gahlot P, Kaur H, Avasthi N, Shweta J. Iran Chem Soc 2022; 19: 4035
11 Yu B, Zheng Y-C, Shi X-J, Qi P-P, Liu H-M. Anti-Cancer Agents Med Chem 2016; 16: 1315
12 Sarmah M, Chutia K, Dutta D, Gogoi P. Org Biomol Chem 2022; 20: 55
13 Sandhu S, Bansal Y, Silakari O, Bansal G. Bioorg Med Chem 2014; 22: 3806
14 Kaddah MM, Fahmi AA, Kamel MM, Ramadan SK, Rizk SA. Synth Commun 2021; 51: 1798
15 Meyer AG, Bissember AC, Hyland CJT. et al. In: Progress in Heterocyclic Chemistry. Gribble GW, Joule. eds. Elsevier; 2021: 565-614
16 Saranya PV, Neetha M, Radhika S, Anilkumar G. J Heterocycl Chem 2021; 58: 673
17 Akhmetova VR, Khabibullina GR, Ibragimov AG. In: N-Heterocycles: Synthesis and Biological Evaluation. Ameta KL, Kant R, Penoni A, Maspero A, Scapinello L. eds Singapore: Springer Nature Singapore; 2022: 191-220
18 Mourya M, Sharma H, Joshi YC, Basak AK. SynOpen 2018; 02: 0128
19 Dorababu A. Polycycl Aromat Compd 2022; 43: 2250
20 Driowya M, Saber A, Marzag H, Demange L, Bougrin K, Benhida R. Molecules 2016; 21: 1032
21 Wiethe RW, Stewart EL, Drewry DH, Gray DW, Mehbob A, Hoekstra WJ. Bioorg Med Chem Lett 2006; 16: 3777
22 Amin MA, Youssef MM, Abdel-Hafez SHJ. Chem Acta 2012; 1: 35
23 Smith, Steven G, Sanchez R, Zhou M-M. Chem Biol 2014; 21: 573
24 El-Gohary NM, El-Kazak AM, Ibrahim MA. J Heterocycl Chem 2020; 57: 716
25 Al-Majedy YK, Kadhum AAH, Al-Amiery AA, Mohamad AB. Syst Rev Pharm 2017; 8: 62
26 Jibroo RN, Mustafa YF. Results Chem 2024; 8: 101611
27 Zeki NM, Mustafa YF. J Mol Struct 2024; 1303: 137601
28 Bhagat PP, Bansode TN. Curr Org Chem 2025; 29: 794
29 Sarkar A, Das D, Paul S. et al. Synlett 2025; 36: 2101
30 Kaur M, Kohli S, Sandhu S, Bansal Y, Bansal G. Anti-Cancer Agents Med Chem 2015; 15: 1032
31 Patel G, Banerjee S. Curr Org Chem 2020; 24: 2566
32 Kaur M, Singh M, Chadha N, Silakari O. Eur J Med Chem 2016; 123: 858
33 Khetmalis YM, Shivani M, Murugesan S, Chandra Sekhar KVG. Biomed Pharmacother 2021; 141: 111842
34 Ziarani GM, Gholamzadeh P, Lashgari N, Hajiabbasi P. ARKIVOC 2013; 1: 470
35 Trost BM, Brennan MK. Synthesis 2009; 18: 3003
36 Galliford CV, Scheidt KA. Angew Chem Int Ed 2007; 46: 8748
37 Daemi H, Rad RR, Barikani M, Adib M. Appl Catal, A 2013; 468: 10
38 Alizadeh A, Rezaiyehraad R, Halvagar M. ChemistrySelect 2019; 4: 130
39 Alizadeh A, Rezaiyehraad R, Roosta A, Halvagar MR. ChemistrySelect 2019; 4: 12049
40 Alizadeh A, Roosta A, Rezaiyehraad R. J Iran Chem Soc 2020; 17: 1123
41 Alizadeh A, Farajpour B, Rezaiyehraad R, Khanpour M. ChemistrySelect 2021; 6: 11925
42 Alizadeh A, Jamal P, Roosta A, Rezaiyehraad R, Liu T-F, Khanpour M. Mol Divers 2021; 25: 701
43 Alizadeh A, Sanjari E, Rezaiyehraad R, Halvagar MR. J Iran Chem Soc 2022; 19: 2459
44 Alizadeh A, Hasanpour H, Rezaiyehraad R. ChemistrySelect 2022; 7: e202203889
45 Sadeghpour M, Olyaei A, Adl A. New J Chem 2021; 45: 5744
46 Ghalehshahi HG, Balalaie S, Aliahmadi A, Moghimi R. Amino Acids 2018; 50: 1461
47 Gordeev KY, Filarin VN, Bondarenko SV. et al. Chem Nat Compd 1990; 26: 143
48 Ghalehshahi HG, Balalaie S, Sohbati HR, Azizian H, Alavijeh MS. Arch Pharm 2019; 352: 1

Supplementary Material

Supplementary Material (PDF) (opens in new window)